CG
GNOM icon

Cutler Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Cutler Group’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-225
Closed -$1K – 2754
2023
Q4 		$1K Buy
+225
New +$9.17K ﹤0.01% 3325

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Cutler Group's GNOM Position: Q1 2024 in Review

Cutler Group sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2024, closing a stake of 25 shares — an estimated $1.14K sold.

Cutler Group first reported a position in GNOM in Q2 2022 and held it in 4 quarters. The position peaked at $8K in Q3 2022. 59 funds tracked by Wall St. Rank hold GNOM as of Q1 2024.

  • Cutler Group reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 25 Global X Genomics & Biotechnology ETF shares in Q1 2024, an estimated $1.14K.
  • Cutler Group first reported a position in Global X Genomics & Biotechnology ETF in Q2 2022 and held it in 4 quarters.
  • Cutler Group's Global X Genomics & Biotechnology ETF position peaked at $8K in Q3 2022.
  • 59 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.